Skip to main content
. 2020 Feb 5;56(2):63. doi: 10.3390/medicina56020063
NAI neuraminidase inhibitors
RCTs randomized controlled trials
OSs observational studies
GRADE Grading of Recommendations, Assessments, Development, and Evaluations
RoB 2.0 cochrane risk-of-bias assessment tool 2.0
ROBINS risk of bias in non-randomized studies of interventionsg
MD difference in meanss
RR risk ratio
CI confidence interval
AE adverse events
SAE serious adverse events